- Home
- LSBK vs DERM Comparison
LSBK vs DERM Comparison
Compare LSBK & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- DERM
- Stock Information
- Founded
- LSBK 1891
- DERM 2014
- Country
- LSBK United States
- DERM United States
- Employees
- LSBK N/A
- DERM N/A
- Industry
- LSBK Savings Institutions
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- LSBK Finance
- DERM Health Care
- Exchange
- LSBK Nasdaq
- DERM Nasdaq
- Market Cap
- LSBK 78.8M
- DERM 87.4M
- IPO Year
- LSBK 2006
- DERM 2021
- Fundamental
- Price
- LSBK $13.73
- DERM $3.66
- Analyst Decision
- LSBK
- DERM Strong Buy
- Analyst Count
- LSBK 0
- DERM 3
- Target Price
- LSBK N/A
- DERM $9.50
- AVG Volume (30 Days)
- LSBK 908.0
- DERM 63.2K
- Earning Date
- LSBK 01-29-2025
- DERM 11-12-2024
- Dividend Yield
- LSBK 5.24%
- DERM N/A
- EPS Growth
- LSBK N/A
- DERM N/A
- EPS
- LSBK 0.74
- DERM N/A
- Revenue
- LSBK $25,338,000.00
- DERM $57,771,000.00
- Revenue This Year
- LSBK N/A
- DERM N/A
- Revenue Next Year
- LSBK N/A
- DERM $36.49
- P/E Ratio
- LSBK $18.50
- DERM N/A
- Revenue Growth
- LSBK N/A
- DERM N/A
- 52 Week Low
- LSBK $13.73
- DERM $2.85
- 52 Week High
- LSBK $14.21
- DERM $6.89
- Technical
- Relative Strength Index (RSI)
- LSBK 58.03
- DERM 29.46
- Support Level
- LSBK $13.22
- DERM $3.54
- Resistance Level
- LSBK $13.51
- DERM $4.00
- Average True Range (ATR)
- LSBK 0.07
- DERM 0.36
- MACD
- LSBK 0.04
- DERM -0.01
- Stochastic Oscillator
- LSBK 69.23
- DERM 12.77
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.